Cargando…
A3 receptor agonist, Cl-IBMECA, potentiate glucose-induced insulin secretion from MIN6 insulinoma cells possibly through transient Ca(2+) entry
Diabetes incidence showed ascending trends in recent years indicating urgent need for new therapeutic agents. Extracellular adenosine signaling showed promising results. However, role of its A3 receptor in pancreatic β-cells proliferation and insulin secretion is not well established. Thus, we aimed...
Autores principales: | Keyvanloo Shahrestanaki, Mohammad, Aghaei, Mahmoud |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6791172/ https://www.ncbi.nlm.nih.gov/pubmed/31620186 http://dx.doi.org/10.4103/1735-5362.253357 |
Ejemplares similares
-
Endogenous and synthetic agonists of GPR119 differ in signalling pathways and their effects on insulin secretion in MIN6c4 insulinoma cells
por: Ning, Y, et al.
Publicado: (2008) -
Dihydroartemisinin Induces Apoptosis in Human Bladder Cancer Cell Lines Through Reactive Oxygen Species, Mitochondrial Membrane Potential, and Cytochrome C Pathway
por: Poupel, Farhad, et al.
Publicado: (2017) -
Novel I(1)-Imidazoline Agonist S43126 Augment Insulin Secretion in Min6 Cells
por: Tesfai, Jerusalem, et al.
Publicado: (2012) -
Metabolomic identification of biochemical changes induced by fluoxetine in an insulinoma cell line (MIN6)
por: Ngamratanapaiboon, Surachai, et al.
Publicado: (2023) -
SUN-313 Insulinoma: Secreting but Not Appearing
por: Patel, Sapna, et al.
Publicado: (2019)